Our recent work demonstrated that ectodysplasin A2 (EDA‐A2) receptor (EDA2R) signalling mediates tumour‐induced muscle wasting by enhancing the expression of muscle atrophy‐related genes, including Atrogin1 and MuRF1.5 Here, FBXO32 is linked to neoplasm.